Characterisation of the Novel Mixed Mu-NOP Peptide Ligand Dermorphin-N/OFQ (DeNo)Mark F. Bird, David G. Lambert, Maria Camilla Cerlesi et al.|PLoS ONE|2016Cited by 55
Synthesis and Evaluation of Carbonic Anhydrase Inhibitors with Carbon Monoxide Releasing Properties for the Management of Rheumatoid ArthritisEmanuela Berrino, Fabrizio Carta, Lisa Milazzo et al.|Journal of Medicinal Chemistry|2019Cited by 48
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivityLaura Micheli, Carla Ghelardini, Lorenzo Di Cesare Mannelli et al.|European Journal of Pharmacology|2015Cited by 23
Antioxidant-Conjugated 1,2,4-Triazolo[4,3-<i>a</i>]pyrazin-3-one Derivatives: Highly Potent and Selective Human A<sub>2A</sub> Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic PainMatteo Falsini, Vittoria Colotta, Daniela Catarzi et al.|Journal of Medicinal Chemistry|2019Cited by 21
Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in ratsLaura Micheli, Girolamo Calò, Lorenzo Di Cesare Mannelli et al.|European Journal of Pharmacology|2015Cited by 19